Product Pipeline
Innovative therapeutics from discovery to market — advancing gene therapy, cell therapy, and biologics
| Therapy Area | Project ID | Product Name | Indication | R&D | Preclinical | Phase I | Phase II | Phase III | Marketed |
|---|
Technology Platforms
Industry-leading bioprocessing and cell therapy platforms driving next‑generation therapeutics
Eukaryotic Cell Fermentation
- Adherent & serum‑free suspension fermentation
- Continuous & stable adherent fermentation process
- Continuous serum‑free suspension culture process
- 20 years of pilot production & clinical drug development (viral injections)
Immune Cell Technology
- First autologous NK cell injection in China (Phase I)
- Process development & manufacturing: NK, DC‑CIK, CAR‑NK, T cells
- Powerful R&D team in immune cell technology & CMC
- Mature & robust immune cell process development
- Precise analytical method development & validation
Prokaryotic Cell R&D & Production
- 50L–200L fermentation equipment
- High‑throughput, large‑scale protein purification
- Advanced process scale‑up platform
- Comprehensive quality control system
How to cooperate
Our Standard Working Process
